| HOME >> BIOLOGY >> TECHNOLOGY |
Genetic Variations Identify Predisposition and Risks of Progression of Vertebral Fracture in US-Caucasian Women
WALTHAM, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Nazneen Aziz, Ph.D., the company's Vice President of Research and Development, will present new research findings on the genetics of osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics, which takes place from Nov. 11-15, 2008, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Dr. Aziz will present poster #2146 on Nov. 13, at the poster session from 4:30 to 6:00 p.m. in Exhibit Hall C.
The title of the presentation is "Association of vertebral fracture with vertebral fracture with Interleukin gene polymorphisms in a large case-control study" highlighting new findings on genetic predisposition risk factors in Caucasian women for vertebral fractures. This study is a collaboration with the Study of Osteoporotic Fracture (SOF), multi-center study on osteoporosis and aging in women greater than or equal to age 65. In addition to adjudication of fractures, SOF has tracked cases of incident breast cancer, stroke, and total and cause-specific mortality. The data include serial measures of bone mineral density, measurements of sex and calcitropic hormones, tests of strength and function, cognitive exams, use of medication, health habits and much more. In 1986, SOF enrolled 9,704 primarily Caucasian women and continues to track these women with clinical visits every two years.
Dr. Aziz commented, "This information should be valuable in guiding the
medical management of high-risk patients and in smarter design of clinical
trial for the enrollment of patients who a
'/>"/>
| SOURCE Interleukin Genetics, Inc. Copyright©2008 PR Newswire. All rights reserved |